• Explore /
  • Poster
  • / Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination.

Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination.

Abstract Poster

Authors

null

Can Aydogdu

Department of Urology, University Hospital, LMU Munich, Munich, Germany

Can Aydogdu , Pia Paffenholz , Ramona Stelmach , Katrin Schlack , Florian Roghmann , Analena Handke , Subhajit Mandal , Marco Schnabel , Axel Merseburger , Philipp Ivanyi , Stefanie Zschaebitz , Christopher Darr , Viktor Grünwald , Christian G. Stief , Jozefina Casuscelli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 436)

DOI

10.1200/JCO.2024.42.4_suppl.436

Abstract #

436

Poster Bd #

H18

Abstract Disclosures

Similar Posters

First Author: Marine Gross-Goupil

First Author: Junjie Zhao

First Author: Daniel Yick Chin Heng

First Author: Antoine Morin Coulombe